New Amsterdam -

: Reported earnings of €0.47 per ordinary share . Entertainment: NBC's "New Amsterdam" TV Series

: Improved slightly to a net loss of $203.8 million for 2025, compared to $241.6 million in 2024 .

: Reported $728.9 million in cash and equivalents as of December 31, 2025, a decrease from the previous year due to R&D spending .

While the show concluded after five seasons in 2023, it remains popular on streaming platforms like .

: A recent 2025 report noted smooth embarkation despite a previous norovirus outbreak on a prior sailing, confirming the crew's effective disinfection protocols . Finance: NewAmsterdam Pharma (NAMS)

: Passengers report exceptional service from friendly staff and high-quality food, especially in the Lido Market Buffet and main dining room .

: Ongoing heavy investment in the development of obicetrapib . Finance: New Amsterdam Invest N.V.